Journal article
Clinical care of children and adolescents with COVID-19: recommendations from the National COVID-19 Clinical Evidence Taskforce
D Fraile Navarro, B Tendal, D Tingay, N Vasilunas, L Anderson, J Best, P Burns, S Cheyne, SS Craig, SJ Erickson, NSS Fancourt, Z Goff, V Kapuya, C Keyte, L Malyon, S McDonald, H White, D Wurzel, AC Bowen, B McMullan
Medical Journal of Australia | Published : 2022
DOI: 10.5694/mja2.51305
Abstract
Introduction: The epidemiology and clinical manifestations of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection are different in children and adolescents compared with adults. Although coronavirus disease 2019 (COVID-19) appears to be less common in children, with milder disease overall, severe complications may occur, including paediatric inflammatory multisystem syndrome (PIMS-TS). Recognising the distinct needs of this population, the National COVID-19 Clinical Evidence Taskforce formed a Paediatric and Adolescent Care Panel to provide living guidelines for Australian clinicians to manage children and adolescents with COVID-19 and COVID-19 complications. Living guidel..
View full abstractGrants
Awarded by Department of Health and Human Services, State Government of Victoria
Funding Acknowledgements
The National COVID--19 Clinical Evidence Taskforce acknowledges the member organisations, partners, governments and funders that support the initiative (online Supporting Information). These guidelines have received funding from the Australian Government Department of Health, the Victorian Government Department of Health and Human Services, the Ian Potter Foundation, the Walter Cottman Endowment Fund managed by Equity Trustees, the Lord Mayor's Charitable Foundation, and the Victorian Government Operational Infrastructure Support Program. David Tingay was supported by a National Health and Medical Research Council Clinical Research Fellowship (Grant ID 1053889).